Systemic scleroderma is a multidisciplinary problem

Systemic scleroderma is a multidisciplinary problem

Bibliographic Details
Main Authors:	N G Guseva, H G Guseva
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2011-04-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/734

Similar Items

The problem of activity in systemic scleroderma
by: N G Guseva, et al.
Published: (2013-06-01)

SUBTYPES OF JUVENILE SYSTEMIC SCLERODERMA
by: M N Slarovoitova, et al.
Published: (2001-04-01)

CLINICAL IMPORTANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA
by: T A Nevskaya, et al.
Published: (2002-02-01)

Scleroderma systematica concurrent with neoplasm
by: Maya Nikolayevna Starovoitova, et al.
Published: (2011-06-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

SCLERODERMA NEPHROPATHY: UNSOLVED PROBLEMS
by: I. E. Bulavko, et al.
Published: (2021-10-01)

Problem of rheumatic and oncological diseases association (pathogenetic and clinical aspects)
by: N G Guseva
Published: (2004-08-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

A Multidisciplinary Approach as a Goal for the Management of Complications in Systemic Scleroderma: A Literature Review and Case Scenario
by: Dariana-Elena Pătrîntașu, et al.
Published: (2023-10-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
by: Michael Macklin, et al.
Published: (2023-02-01)

DIFFERENTIAL DIAGNOSIS IN JUVENILE SCLERODERMA
by: M.K. Osminina, et al.
Published: (2008-01-01)

DIFFERENTIAL DIAGNOSIS IN JUVENILE SCLERODERMA
by: M.K. Osminina, et al.
Published: (2008-01-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)

Antiphospholipid Antibodies and Systemic Scleroderma
by: Muhammed Mubarak, et al.
Published: (2013-12-01)

Antiphospholipid Antibodies and Systemic Scleroderma
by: Awa Oumar Touré, et al.
Published: (2013-03-01)

SCLERODERMA-LIKE MASK OF OSTEOPOIKILIA
by: R G Mukhina, et al.
Published: (2002-04-01)

Therapy for digital ulcers in patients with systemic scleroderma
by: M. N. Starovoitova, et al.
Published: (2019-01-01)

Bone mineral density in patients with systemic scleroderma
by: O. V. Dobrovolskaya, et al.
Published: (2019-03-01)

PROBLEMS AND PARADOXES OF INFORMATION SECURITY IN MODERN MANAGEMENT
by: Elena P. Guseva
Published: (2016-08-01)

DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019-05-01)

Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
by: Leask, A, et al.
Published: (2005)

Academician E.M. Tareyev and problems of rheumatology (on the occasion of the 115th anniversary of his birth
by: V A Nasonova, et al.
Published: (2011-08-01)

Fibrosing arthropathy in juvenile scleroderma
by: D. A. Dibrov, et al.
Published: (2021-04-01)

Biomarkers of interstitial lung disease in systemic scleroderma and their significance
by: D. V. Khorolsky, et al.
Published: (2023-02-01)

OVERDENTURE IN SCLERODERMA'S PATIENT
by: , Elin Hertiana
Published: (2012)

Human otopathology in scleroderma
by: Melissa Castillo‐Bustamante, et al.
Published: (2023-12-01)

Finger Printlessness in Scleroderma
by: Milad HOSSEINIALHASHEMI, et al.
Published: (2016-08-01)

Scleroderma lung disease
by: Joshua J. Solomon, et al.
Published: (2013-03-01)

Markers of bone metabolism in patients with systemic scleroderma
by: Yu. Yu. Ivanova, et al.
Published: (2020-12-01)

THE CASE OF THE DEBUT OF SYSTEMIC SCLERODERMA IN A PATIENT AGED 10
by: А. V. BURLUTSKAYA, et al.
Published: (2018-07-01)

Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)

Scleroderma. A case presentation.
by: Rubén Bembibre Taboada, et al.
Published: (2005-08-01)

SCLERODERMA: A CASE REPORT*
by: Gülay Altan, et al.
Published: (2015-04-01)

CELL M1CROCH1MERISIS - NEW HYPOTHESIS OF AUTOIMMUNE DISEASES
by: N G Guseva
Published: (2002-06-01)

EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA
by: R T Alekperov, et al.
Published: (2011-04-01)

Uncommon skeletal findings in systemic sclerosis (scleroderma)
by: Betsie van der Walt, et al.
Published: (2002-03-01)

Skin lesion in scleroderma systematica
by: Maya Nikolayevna Starovoitova
Published: (2010-04-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

A clinical case of late diagnosis of systemic scleroderma
by: T.M. Shibaeva, et al.
Published: (2022-11-01)